In 2024, Goldstein and Goldstein published results from an observational study of 21 men with various sexual dysfunctions (low libido, ED, trouble with orgasm, etc.) who were given subcutaneous bremelanotide to use as needed
Retatrutide is an investigational triple hormone receptor agonist that acts across three receptors, including GIP receptors, GLP-1, and glucagon pathways, whereas Ozempic does not, and it is not FDA-approved
CagriSema is a fixed-dose combination of cagrilintide plus semaglutide
Denmeade, S
Mechanism summary sourced from pep-pedia.org and the published peptide research literature
Med Matrix has one clinic, at 198 Maine Mall Road in South Portland, and serves patients across Maine and New Hampshire